Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Slide Scanner Patent Awarded

April 21, 2011 7:18 am | News | Comments

The U.S. Patent and Trademark Office has issued Aperio a patent entitled, "Data Management in a Linear-array-based Microscope Slide Scanner."

TOPICS:

High Throughput Cell Analysis

April 21, 2011 7:14 am | Product Releases | Comments

The new xCELLigence RTCA HT Instrument from Roche merges the power and flexibility of xCELLigence System technology with high-throughput analyses and workflows for automated screening applications.

TOPICS:

Laboratory Baths and Circulators

April 21, 2011 7:06 am | Product Releases | Comments

Cole-Parmer has redesigned and updated its line of Polystat circulating baths and immersion circulators, which offer temperature stability for a range of laboratory applications including Polystat Open Heating Circulating Baths and Polystat Stainless Steel Heating Circulating Baths.

TOPICS:
Advertisement

Clinical Trial of Cell Therapy for Stroke Disability

April 21, 2011 7:04 am | News | Comments

The Stanford University School of Medicine and SanBio Inc. announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from previous stroke injuries.

TOPICS:

Orphan Drug Designation for HCMV Inhibitor

April 21, 2011 7:02 am | News | Comments

AiCuris announced that AIC246, the company’s inhibitor against the human cytomegalovirus HCMV has been granted Orphan Drug designation for the prevention of HCMV disease.

TOPICS:

CDS Software Control

April 21, 2011 6:59 am | Product Releases | Comments

Thermo Fisher Scientific Inc., announced the availability of a new Thermo Scientific Atlas Chromatography Data System (CDS) instrument control software for the Shimadzu Prominence and Prominence XR HPLC.

TOPICS:

SPE Methods Development Web Tool

April 21, 2011 6:42 am | Product Releases | Comments

Phenomenex Inc. introduces the Solid Phase Extraction (SPE) Method Development Tool, an online resource that develops methods across a variety of sample matrices and compounds.

TOPICS:

Interactive Workspace

April 20, 2011 8:16 am | Product Releases | Comments

Chemical Abstracts Service introduced SciPlanner, an interactive workspace that enables scientists to more quickly identify synthesis options for designing the best research pathways and approaches.

TOPICS:
Advertisement

Wireless Monitoring

April 20, 2011 8:13 am | Product Releases | Comments

Thermo Fisher Scientific Inc. introduced its Smart-Vue wireless monitoring solution. Smart-Vue protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure.

TOPICS:

Gilead And Microdose Announce Collaboration

April 20, 2011 8:02 am | News | Comments

Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637.

TOPICS:

Cumberland Pharma Buys Rights to Drug Candidate

April 20, 2011 7:58 am | News | Comments

Cumberland Pharmaceuticals Inc. said it acquired the rights to a molecule named ifetroban and will test it as a potential in-hospital treatment for a condition that involves progressive kidney failure.

TOPICS:

Decoding Cancer Patients' Genomes A Powerful Tool

April 20, 2011 7:55 am | News | Comments

Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.

TOPICS:

First Patient Treated in CicloMulsion Trial

April 20, 2011 7:52 am | News | Comments

NeuroVive Pharmaceutical and Hospices Civils de Lyon has dosed the first of 1,000 enrollees in its phase 3 trial of CicloMulsion for patients undergoing PCI for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.

TOPICS:

Anavex Begins Alzheimer’s Trial

April 20, 2011 7:38 am | News | Comments

Anavex Life Sciences Corp. announced that the first healthy human volunteers have been initially dosed in its Phase 1 clinical trial to evaluate ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease.

TOPICS:

Forest Profits Up Over $322M

April 20, 2011 7:27 am | News | Comments

Forest Laboratories Inc. said its net income jumped in the fiscal fourth quarter compared to last year, when it made a large payment to AstraZeneca PLC to get the rights to a potential antibacterial drug cocktail.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading